Education
About Us
Working with TipRanks
Follow Us
PharmaCielo (PCLOF)
OTHER OTC:PCLOF
Total Valuation
PharmaCielo has a market cap or net worth of $5.62M. The enterprise value is $34.40M.
Market Cap$5.62M
Enterprise Value$34.40M
Share Statistics
PharmaCielo has 175,724,660 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding175,724,660
Owned by Insiders8.29%
Owned by Institutions<0.01%
Financial Efficiency
PharmaCielo’s return on equity (ROE) is 1.22 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)1.22
Return on Assets (ROA)-0.50
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee12.98K
Profits Per Employee-34.11K
Employee Count268
Asset Turnover0.19
Inventory Turnover1.83
Valuation Ratios
The current PE Ratio of PharmaCielo is -1.53. PharmaCielo’s PEG ratio is 0.02.
PE Ratio-1.53
PS Ratio2.68
PB Ratio-1.87
Price to Fair Value-1.87
Price to FCF-7.12
Price to Operating Cash Flow-7.12
PEG Ratio0.02
Income Statement
In the last 12 months, PharmaCielo had revenue of 3.48M and earned -9.14M in profits. Earnings per share was -0.01.
Revenue3.48M
Gross Profit730.88K
Operating Income0.00
Pretax Income-9.14M
Net Income-9.14M
EBITDA-4.60M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -1.97M and capital expenditures -2.00, giving a free cash flow of -1.97M billion.
Operating Cash Flow-1.97M
Free Cash Flow-1.97M
Free Cash Flow per Share-0.01
Dividends & Yields
PharmaCielo pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.15
52-Week Price Change-63.64%
50-Day Moving Average0.05
200-Day Moving Average0.07
Relative Strength Index (RSI)45.58
Average Volume (3m)11.73K
Important Dates
PharmaCielo upcoming earnings date is Jun 2, 2025, TBA Not Confirmed.
Last Earnings DateFeb 28, 2025
Next Earnings DateJun 2, 2025
Ex-Dividend Date―
Financial Position
PharmaCielo as a current ratio of 0.11, with Debt / Equity ratio of -273.07%
Current Ratio0.11
Quick Ratio0.04
Debt to Market Cap1.46
Net Debt to EBITDA-4.43
Interest Coverage Ratio0.00
Taxes
In the past 12 months, PharmaCielo has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
PharmaCielo EV to EBITDA ratio is -7.47, with an EV/FCF ratio of -17.47.
EV to Sales9.88
EV to EBITDA-7.47
EV to Free Cash Flow-17.47
EV to Operating Cash Flow-17.47
Balance Sheet
PharmaCielo has $147.94K in cash and marketable securities with C$0.00 in debt, giving a net cash position of $20.38M billion.
Cash & Marketable Securities$147.94K
Total DebtC$0.00
Net Cash$20.38M
Net Cash Per Share$0.12
Tangible Book Value Per Share-$0.04
Margins
Gross margin is 19.51%, with operating margin of 0.00%, and net profit margin of -262.70%.
Gross Margin19.51%
Operating Margin0.00%
Pretax Margin-262.70%
Net Profit Margin-262.70%
EBITDA Margin-132.27%
EBIT Margin-168.63%
Analyst Forecast
The average price target for PharmaCielo is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―